Menu

Prelude Therapeutics Incorporated PRLD

Full chart Compare
Set alert

Price alert · PRLD

All alert types
3.56 USD 0.00 (+0.00%)

At closeNov 5, 2026, 4:00 PM EST

3.50 -0.06 -1.55%

After hours · Nov 5, 4:00 PM ET

Day range unavailable

1.17 52-week range 6.83
YTD
+22.59%
1 year
+155.76%

Revenue & Expenses

Other Income → Expenses: $5.07MOther Operating Income → Expenses: $1.71MExpenses → Selling, General & Admin: $22.41MExpenses → Research & Development: $94.30MGross Profit → Expenses: $10.43MRevenue → Gross Profit: $10.43MRevenue → Cost of Revenue: $1.71MNet Loss → Expenses: $99.50MOther Income$5.07MOther Operating Income$1.71MGross Profit$10.43MNet Loss$99.50MCost of Revenue$1.71MExpenses$116.71MSelling, General & Admin$22.41MResearch & Development$94.30MRevenue$12.14M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

PRLD annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
12.14M7.00M000
12.14M7.00M000
12.14M7.00M000
116.71M146.71M132.28M123.54M113.73M
94.30M118.00M103.39M92.89M86.78M
22.41M28.72M28.88M30.65M26.96M
-104.57M-139.71M-132.28M-123.54M-113.73M
-99.50M-127.17M-121.83M-115.44M-111.69M
-99.50M-127.17M-121.83M-115.44M-111.69M
-99.50M-127.17M-121.83M-115.44M-111.69M
-99.50M-127.17M-121.83M-115.44M-111.69M
-1.29-1.68-2.02-2.44-2.43
-1.29-1.68-2.02-2.44-2.43
-1.29-1.68-2.02-2.44-2.43
-99.50M-127.17M-121.83M-115.44M-111.69M
-99.50M-127.17M-121.83M-115.44M-111.69M
76.96M75.81M60.36M47.37M46.05M
76.96M75.81M60.36M47.37M46.05M